Our portfolio company ASPIVIX SA announced last week the completion of and interim analysis results from its Phase I first-in-women trial. The two-phase ADVANCE Women trial is assessing the usability, efficacy, and safety of the investigational CAREVIX, the innovative device designed as a modern and gentler alternative. Warmest congratulations on your achievement, ASPIVIX!
Funding, Innovation, Press Release
Annaida Technologies: Providing The Technology To Measure The Inaccessible
03
Dec
Dec
Our portfolio company Annaida is developing a medical device that will allow doctors to screen embryos and determine the most viable to increase chances of success. Their technology can be used to detect and quantify various chemical compounds in microscopic entities, such as human embryos or stem cells, in a non-invasive way. Annaida Technologies […]
22
Oct
Oct
HEMEX is delighted to announce our exciting new partnership with QualityKick. A compliant, cloud-based, and pre-validated solution for Quality Management in Life Sciences. This partnership enables us to provide healthcare start-ups with a complete range of packages to ensure no Quality Management System gets left behind.
03
Sep
Sep
ender diagnostics announced today a collaboration with Swiss International Air Lines to test all long-haul cabin crew members for SARS-CoV-2. HEMEX is proud to support the ender team with clinical, regulatory, and marketing services. HEMEX’s regulatory experts will support the CE-certification of the test as an in vitro diagnostic medical device under […]
18
Aug
Aug
Quality and comfortable sleep is vital for our well-being. Our portfolio company Sleepiz has developed a unique software and hardware solution to help people suffering from sleep disorders. Sleep disorders can cause a multitude of severe problems in your daily life. One common disorder is sleep apnea. If you suffer from sleep apnea, you may […]
12
Aug
Aug
ender diagnostics launches their second CE-certified COVID-19 test, which will enable rapid, and high-volume testing in schools, manufacturing facilities, hospitals, and care homes. One of the essential elements for the control of COVID-19 is reliable and rapid testing. However, testing capacity is a significant global challenge due to shortages in healthcare services. Our portfolio company […]
22
Jun
Jun
Our portfolio company ARTIDIS announces today promising data from their first prospective study conducted at the Breast Center in Basel, Switzerland. The spin-off from the Biozentrum at the University of Basel has succesfully developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization. HEMEX AG is a privately-owned Swiss investment and consulting company headquartered […]
16
Jun
Jun
Swiss-based start-up ender diagnostics develops rapid molecular tests for the detection of SARS-CoV-2. The first rapid test has just been CE -certified and can now be used in laboratories worldwide. What makes the ender LAB and subsequent ender MAS test outstanding is not just that the result is obtained within 30 minutes, but also that […]
- 1
- 2